In a report released yesterday, Elyse Greenspan from Wells Fargo maintained a Buy rating on Metlife (MET – Research Report), with a price target of $94.00. The company’s shares closed yesterday at $79.63.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Greenspan covers the Financial sector, focusing on stocks such as Progressive, Allstate, and American International Group. According to TipRanks, Greenspan has an average return of 7.5% and a 59.92% success rate on recommended stocks.
Currently, the analyst consensus on Metlife is a Strong Buy with an average price target of $93.45.
The company has a one-year high of $89.05 and a one-year low of $65.21. Currently, Metlife has an average volume of 3.48M.
Based on the recent corporate insider activity of 110 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MET in relation to earlier this year. Last month, BILL PAPPAS, the EVP, Global Tech. & Ops of MET sold 26,000.00 shares for a total of $2,092,480.00.
Read More on MET: